Shuttle Pharmaceuticals (NASDAQ: SHPH) is advancing its mission to revolutionize prostate cancer treatment. On April 10, 2025, the company announced…
Read More »Biotech
The broader market experienced mixed performance to start the week, with major indices continuing to display volatility. On Monday, Dow…
Read More »
Summary First-Mover Advantage: Soleno has the market to itself until competition intensifies. High Sales Potential: Projected sales of $876 million…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is making headlines in April, launching its innovative alcohol detox drink, unbuzzd™,…
Read More »
As President Trump’s sweeping tariffs and immigration policies continue to weigh on financial markets, many investors have taken a step…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is riding a wave of optimism following robust financial improvements, promising clinical…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) isn’t standing still. The biopharmaceutical innovator behind the clinically validated…
Read More »
Shares of 23andMe (NASDAQ: ME) imploded this week after the embattled genetic testing company filed for Chapter 11 bankruptcy and…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, reported the closing…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, has taken two…
Read More »